EVH – evolent health, inc class a (US:NASDAQ)
Stock Stats
News
Evolent Health, Inc. (NYSE: EVH) is now covered by analysts at Citigroup Inc.. They set a "buy" rating and a $40.00 price target on the stock.
Evolent To Release First Quarter 2024 Financial Results on Thursday, May 9, 2024
Exclusive: Inside Wiz's acquisition of Gem Security [Fortune]
Define Ventures Welcomes Frank Williams as Venture Partner [Yahoo! Finance]
Recent 7.4% pullback isn't enough to hurt long-term Evolent Health (NYSE:EVH) shareholders, they're still up 134% over 5 years [Yahoo! Finance]
Form ARS Evolent Health, Inc. For: Dec 31
Form DEFA14A Evolent Health, Inc.
Form DEF 14A Evolent Health, Inc. For: Jun 06
Form 4 Evolent Health, Inc. For: Jul 01 Filed by: Tutewohl Steve
Form SC 13G/A Evolent Health, Inc. Filed by: JPMORGAN CHASE & CO
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.